~~<i id='668E80A836'><strike id='668E80A836'><tt id='668E80A836'><pre id='668E80A836'></pre></tt></strike></i>~~

Home» Wikipedia» Wikipedia

Wikipedia

author：knowledge 2025-10-03 00:49:21 Page View：626

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Florida group launches initiative to get abortion constitutional amendment on 2024 ballot
Next article： Cancer drug shortages should be causing more outrage

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

STAT Madness 2024: Meet the contenders

The64contestantswhosediscoveriesandinnovationshavebeenselectedforthe2024editionofSTATMadnesscomefrom

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

1:10PresidentJoeBidenparticipatesinaceremonialarrivalandinspectionofthehonorguardwithBritain'sKingCh